Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cellular Oncology (Dordrecht, Netherlands)|June 11, 2025
Absence of lipopolysccharide (LPS) expression in breast cancer cellsNoel F C C de Miranda, Vincent T H B M Smit, Manon van der Ploeg, et al.Cancers|August 26, 2022
A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic CancerThomas Brouwer, Marieke Ijsselsteijn, Jan Oosting, et al.Nature Methods|August 29, 2024
Integration of mass cytometry and mass spectrometry imaging for spatially resolved single-cell metabolic profilingJoana B Nunes, Marieke E Ijsselsteijn, Tamim Abdelaal, et al.Gut|November 28, 2022
Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesisJessica Roelands, Manon van der Ploeg, Marieke E Ijsselsteijn, et al.Anti-Cancer Drugs|March 24, 2022
The identification of the anthracycline aclarubicin as an effective cytotoxic agent for pancreatic cancerThomas P Brouwer, Sabina Y van der Zanden, Manon van der Ploeg, et al.Nature Cancer|April 16, 2025
Dual modulation of cytotoxic and checkpoint receptors tunes the efficacy of adoptive Delta One T cell therapy against colorectal cancerRafael Blanco-Domínguez, Leandro Barros, Mariana Carreira, et al.Journal for Immunotherapy of Cancer|February 15, 2023
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burdenJitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn, et al.Genome Medicine|January 1, 2020
Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4Jitske van den Bulk, Els M E Verdegaal, Dina Ruano, et al.Journal for Immunotherapy of Cancer|January 25, 2024
Multimodal profiling of chordoma immunity reveals distinct immune contexturesSiddh van Oost, Debora M Meijer, Marieke E Ijsselsteijn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2023
Neoantigen Targetability in Progressive Advanced MelanomaJitske van den Bulk, Els M E Verdegaal, Manon van der Ploeg, et al.Pageof 2